Breakthrough Fusarium solani infection in a patient with acute myeloid leukemia receiving posaconazole prophylaxis

Invasive fungal breakthrough infections, fungal colonization and emergence of resistant strains in high-risk patients receiving antifungal prophylaxis with posaconazole: real-life data from a single-centre institutional retrospective observational study

(2012) J. Auberger et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Posaconazole prophylaxis during front-line chemotherapy of acute myeloid leukemia: a single-center, real-life experience

(2011) C. Girmenia et al.   HAEMATOLOGICA

Comparative clinical effectiveness of prophylactic voriconazole/posaconazole to fluconazole/itraconazole in patients with acute myeloid leukemia/myelodysplastic syndrome undergoing cytotoxic chemotherapy over a 12-year period

(2011) M. R. Ananda-Rajah et al.   HAEMATOLOGICA

Disseminated Fusariosis Occurring in Two Patients Despite Posaconazole Prophylaxis

(2011) P. Bose et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Clinical effectiveness of posaconazole prophylaxis in patients with acute myelogenous leukaemia (AML): a 6 year experience of the Cologne AML cohort

(2010) J. J. Vehreschild et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Fatal Rhizopus Pneumonia in Allogeneic Stem Cell Transplant Patients Despite Posaconazole Prophylaxis: Two Cases and Review of the Literature

(2009) Lazaros J. Lekakis et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION